ReWalk exoskeletons to be covered under Medicare
Photo | Courtesy of ReWalk
A demonstration of ReWalk's exoskeleton systems
Marlborough’s ReWalk Robotics, a medical device company that manufactures a breakthrough exoskeleton for neurological injuries, will be included in Medicare coverage for 2024.
The Centers for Medicare & Medicaid Services on Wednesday ruled that exoskeletons would be covered in the Medicare brace benefit category.
“Finalization of this rule by CMS is a major milestone in our efforts to expand access to this life-changing technology for the substantial proportion of the spinal cord injury community with Medicare coverage,” said Larry Jasinski, CEO of ReWalk Robotics, in a Thursday press release. “The vision at ReWalk has always been to enable broad access to walking, climbing curbs or stairs, and standing during eye-to-eye conversations in everyday life for individuals living with spinal cord injury.”
The ReWalk system was given U.S. Food and Drug Administration approval in 2021. In 2022, it sought to reclassify its product as artificial legs to fall under the-requirements for Medicare coverage.
The company in August completed the $19 million acquisition of a gravity-defying technology to bolster its product.
The coverage under Medicare will potentially expedite the ability for Medicare-covered patients to gain access to the technology, according to the ruling.
WBJ Web Partners
Most Recent
Most Recent
0 Comments